Preliminary Endoscopic Technical Report of a New Silicone Intragastric Balloon in the Treatment of Morbid Obesity

Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis

“…We reviewed the abstract of the 213 articles identified and rejected 196 because they did not meet the inclusion criteria. Seven of them duplicated patients that had been reported in other studies [13][14][15][16][17][18][19] and two of them were excluded by our language restrictions (one German [20] and one Polish [21] article). We requested the remaining 17 articles, but we did not obtain one of them [22].…”

Initial Japanese Experience with Intragastric Balloon Placement

“…Conflicting results on their efficacy have been reported, and complications have been relatively frequent. In 1999, a new balloon, the BioEnterics® Intragastric Balloon (BIB®) system, which has a spherical shape and higher volume of saline (400-700 ml) was introduced [11,12]. Extensive clinical experiences with the BIB® system have shown a low complication rate, efficacy in weight loss, and improvement of comorbidities [13,14].…”

BioEnterics Intragastric Balloon for Treatment of Morbid Obesity in Prader–Willi Syndrome: Specific Risks and Benefits

“…BioEnterics Intragastric Balloon (BIB) is an endoscopic device for temporary nonsurgical and nonpharmaceutical treatment of morbid obesity [10]. It consists of a silicone smooth elastic balloon with a self-sealing radiopaque valve designed to remain in the gastric cavity for a period of 6 months [11].…”